Satoru Hagiwara

11PUBLICATIONS
12CO-AUTHORS
Predictive and prognostic markersCancer therapy (excl. chemotherapy and radiation therapy)Clinical social work practiceAged care nursingEnvironmental epidemiology
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (11)

|Jul 28, 2026
Long-Term Real-World Evaluation of Tofacitinib's Effectiveness and Safety in Japan: Insights Into Optimal Timing for Dose Reduction.

|Dec 20, 2024
A Case of Fibrolamellar Hepatocellular Carcinoma in Which Tumor Control Was Achieved by Re-Administering Atezolizumab and Bevacizumab.

Satoru Hagiwara, Itsuki Oda, Kazuomi Ueshima

|Oct 28, 2024
JAK Inhibitor Upadacitinib Induces Remission in Refractory Immune-Related Colitis Triggered by CTLA-4 and PD-1 Inhibitor Combination Therapy in Malignant Pleural Mesothelioma: A Case Report.

Masashi Kono, Yoriaki Komeda, Hisato Kawakami

|Mar 04, 2024
Hereditary hemorrhagic telangiectasia with hepatic arteriovenous shunt diagnosed due to liver damage.

Satoru Hagiwara, Toru Takase, Itsuki Oda

|Jan 10, 2024
Hemophagocytic lymphohistiocytosis induced by nivolumab/ipilimumab combination therapy: A case of lung adenocarcinoma that responded to early steroid pulse therapy.

Satoru Hagiwara, Junko Tanizaki, Hidetoshi Hayashi

|Mar 10, 2023
Long-Term Survival of More than 5 Years with Maintenance Therapy Using Single-Agent Pemetrexed in a Patient with Diffuse Malignant Peritoneal Mesothelioma.

Yasuo Otsuka, Yoriaki Komeda, Masayuki Takeda

Pageof 2

Frequent Collaborators

4 joint publications

Yoriaki Komeda

2 joint publications

Mamoru Takenaka

2 joint publications

Masatoshi Kudo

1 joint publications

Yasuo Otsuka